The FDA is currently conducting an inspection of the facility, and its preliminary findings have raised concerns about sterility assurance for all products produced and distributed by the facility.
The recall was not based on reports of patients with infections from Ameridose products, but rather a precaution since Ameridose shares common management with New England Compounding Center, the firm associated with the compounding drugs linked to the meningitis outbreak.
For a full list of Ameridose products, visit their site.
More Articles on Anesthesia:
Children Less Stressed Before Anesthesia Induction After Watching Videos
Significant Pain Relief for Abdominal, Pelvic Surgeries Provided by Dicolfenac
MedNet Hires Anesthesiologist Dr. Brian Waltmann as Medical Director
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
